The intravenous formulation of fosfomycin has a novel mechanism of action an no known cross-resistance to other antibiotic ...

Objective and design: The use of proton pump inhibitors in acid-related diseases such as peptic ulcer or erosive reflux oesophagitis is well established. The aim of the current nationwide, multicentre ...

Please provide your email address to receive an email when new articles are posted on . DENVER — Subcutaneous administration of ocrelizumab showed similar safety and efficacy profiles to IV ...

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with patient-specific factors guiding delivery method choices, while ongoing innovation and ...

The use of intravenous magnesium sulphate for acute respiratory distress syndrome is associated with a lower rate of ...

Amivantamab and lazertinib combination therapy shows high efficacy in EGFR-mutated NSCLC, with an 82% objective response rate in the PALOMA-2 trial. Subcutaneous administration of amivantamab reduces ...

The U.S. Food and Drug Administration on Friday approved Roche's under-the-skin injection to treat patients with multiple ...